Literature DB >> 32297330

Reactive lymphocytes in patients with COVID-19.

Vanessa C L Chong1, Kian Guan Eric Lim1, Bingwen Eugene Fan1, Stephrene S W Chan1, Kiat H Ong1, Ponnudurai Kuperan1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32297330      PMCID: PMC7262365          DOI: 10.1111/bjh.16690

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
From 23 January to 27 February 2020, Singapore had 96 COVID‐19 cases confirmed by real time reverse transcriptase‐polymerase chain reaction (RT‐PCR) for SARS‐CoV‐2. We examined the peripheral blood films of 32 patients and found reactive lymphocytes as shown in the top images in 23 cases (72%). This is in stark contrast to the pattern with coronavirus responsible for the 2003 SARS outbreak where reactive lymphocytes of this type were not present in a review of 185 SARS cases in Singapore and were present in only 15·2% of 138 cases in Hong Kong. , Reactive lymphocytes are commonly seen in other viral diseases such as dengue fever and infectious mononucleosis. They have varied morphological features. The most common subtype seen in our COVID‐19 patients displayed a distinctive abundant pale blue cytoplasm that often abuts adjacent red blood cells (top left and right). Strikingly, lymphoplasmacytoid lymphocytes were present in 16 out of 23 patients (bottom images: left, right and centre). These are small mature lymphocytes with condensed chromatin and an eccentric nucleus, occasionally with a paranuclear hof. Lymphoplasmacytoid lymphocytes are also seen in dengue fever and in several B‐cell non‐Hodgkin lymphomas. Reactive lymphocytes of both types can coexist in a single peripheral blood film in COVID‐19 patients.
  2 in total

1.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

2.  Haematological parameters in severe acute respiratory syndrome.

Authors:  W J Chng; H C Lai; A Earnest; P Kuperan
Journal:  Clin Lab Haematol       Date:  2005-02
  2 in total
  8 in total

1.  Overview of the Haematological Effects of COVID-19 Infection.

Authors:  T M Wiggill; E S Mayne; J L Vaughan; S Louw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.

Authors:  S Vivek Anand; Yao Kang Shuy; Poay Sian Sabrina Lee; Eng Sing Lee
Journal:  Int J Environ Res Public Health       Date:  2021-08-30       Impact factor: 4.614

Review 3.  Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.

Authors:  Negin Ebrahimi; Saeed Aslani; Farhad Babaie; Maryam Hemmatzadeh; Ramin Hosseinzadeh; Zeinab Joneidi; Zahra Mehdizadeh Tourzani; Nafiseh Pakravan; Hamed Mohammadi
Journal:  Int Immunopharmacol       Date:  2020-10-10       Impact factor: 4.932

4.  Development of infectious mononucleosis as an unusual manifestation of COVID-19.

Authors:  Masatoshi Fukuda; Yuta Amano; Chisako Masumura; Makoto Ogawa; Hidenori Inohara
Journal:  Auris Nasus Larynx       Date:  2021-04-12       Impact factor: 2.119

Review 5.  Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients.

Authors:  Emanuela Romano; Steve Pascolo; Patrick Ott
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

6.  Peripheral Blood Examination Findings in SARS-CoV-2 Infection.

Authors:  Alia Nazarullah; Christine Liang; Andrew Villarreal; Russell A Higgins; Daniel D Mais
Journal:  Am J Clin Pathol       Date:  2020-08-05       Impact factor: 2.493

7.  A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study.

Authors:  Joachim Linssen; Anthony Ermens; Marvin Berrevoets; Michela Seghezzi; Giulia Previtali; Simone van der Sar-van der Brugge; Henk Russcher; Annelies Verbon; Judith Gillis; Jürgen Riedl; Eva de Jongh; Jarob Saker; Marion Münster; Imke Ca Munnix; Anthonius Dofferhof; Volkher Scharnhorst; Heidi Ammerlaan; Kathleen Deiteren; Stephan Jl Bakker; Lucas Joost Van Pelt; Yvette Kluiters-de Hingh; Mathie Pg Leers; Andre J van der Ven
Journal:  Elife       Date:  2020-11-26       Impact factor: 8.140

8.  Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients.

Authors:  Jennifer Osman; Jérome Lambert; Marie Templé; Floriane Devaux; Rémy Favre; Claire Flaujac; Delphine Bridoux; Stéphanie Marque-Juillet; Fabrice Bruneel; François Mignon; Ernesto Diaz-Flores; Véronique Hentgen; Alix Greder-Belan; Reza Azarian; Mehrsa Koukabi; Philippe Rousselot; Victoria Raggueneau; Benjamin Manéglier
Journal:  Br J Haematol       Date:  2020-07-05       Impact factor: 8.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.